Form 4: Sight Sciences CLO Sells Shares for Tax Liability

Sight Sciences' Chief Legal Officer, Jeremy B. Hayden, sold 11,170 shares of common stock across two transactions in early January 2026 to cover tax liabilities from restricted stock unit vesting.

Summary

• Chief Legal Officer Jeremy B. Hayden sold a total of 11,170 shares of Sight Sciences, Inc. common stock.
• The sales occurred on January 5, 2026, and January 6, 2026.
• On January 5, 2026, 9,385 shares were sold at a weighted average price of $7.82 per share, with prices ranging from $7.71 to $7.97.
• On January 6, 2026, 1,785 shares were sold at a weighted average price of $7.48 per share, with prices ranging from $7.39 to $7.67.
• These transactions were executed to cover tax liabilities associated with the vesting of restricted stock units.
• The sales were conducted under a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.
• Following these transactions, Jeremy B. Hayden beneficially owns 245,420 shares of common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale for tax purposes, which is a neutral event. The transaction was pre-planned under a 10b5-1 plan, mitigating any negative sentiment associated with discretionary insider selling.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale not based on new material non-public information.

Negatives

• A reduction in insider ownership, even for tax purposes, slightly decreases management's direct equity stake.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.

Industry Context

This Form 4 filing details an insider stock transaction for tax purposes and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but for a routine tax purpose, so minimal impact. The pre-planned nature (10b5-1) reduces concerns about discretionary selling.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned insider sale of shares by the Chief Legal Officer to cover tax liabilities from RSU vesting. Such transactions are common and do not typically signal a change in management's outlook or the company's fundamentals. Given the non-discretionary nature of the sale, it provides no new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Sight Sciences, SGHT, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Liability, Jeremy B. Hayden, Chief Legal Officer, 10b5-1 plan